Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials

作者: DanielL Dries , DerekV Exner , BernardJ Gersh , MichaelJ Domanski , MyronA Waclawiw

DOI: 10.1016/S0735-1097(98)00297-6

关键词:

摘要: Abstract Objective. This study undertook to determine if the presence of atrial fibrillation in patients with asymptomatic and symptomatic left ventricular dysfunction was associated increased mortality and, so, whether increase could be attributed progressive heart failure or arrhythmic death. Background. Atrial is a common condition potential impact hemodynamics progression systolic as well electrophysiologic substrate for arrhythmias. The available data do not conclusively define effect on prognosis failure. Methods. A retrospective analysis Studies Left Ventricular Dysfunction Prevention Treatment Trials conducted that compared those sinus rhythm at baseline risk all-cause mortality, pump-failure death Results. baseline, rhythm, had greater (34% vs. 23%, p Conclusions. an largely explained by These suggest dysfunction.

参考文章(29)
D. Soyeur, H. Kulbertus, Hemodynamic Consequences of Cardiac Arrhythmias Update in Intensive Care and Emergency Medicine. pp. 181- 193 ,(1988) , 10.1007/978-3-642-83453-0_13
Daniel L. Dries, Yves D. Rosenberg, Myron A. Waclawiw, Michael J. Domanski, Ejection Fraction and Risk of Thromboembolic Events in Patients With Systolic Dysfunction and Sinus Rhythm: Evidence for Gender Differences in the Studies of Left Ventricular Dysfunction Trials Journal of the American College of Cardiology. ,vol. 29, pp. 1074- 1080 ,(1997) , 10.1016/S0735-1097(97)00019-3
Jack E Juni, Lucy Wu, Jerold W Wallis, None, Gated cardiac blood pool studies in atrial fibrillation: role of cycle length windowing European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 18, pp. 23- 27 ,(1991) , 10.1007/BF00177680
David M Clark, Vance J Plumb, Andrew E Epstein, G.Neal Kay, Hemodynamic Effects of an Irregular Sequence of Ventricular Cycle Lengths During Atrial Fibrillation Journal of the American College of Cardiology. ,vol. 30, pp. 1039- 1045 ,(1997) , 10.1016/S0735-1097(97)00254-4
HernanC Doval, DanielR Nul, HugoO Grancelli, SergioV Perrone, GuillermoR Bortman, Rodolfo Curiel, Randomised trial of low-dose amiodarone in severe congestive heart failure The Lancet. ,vol. 344, pp. 493- 498 ,(1994) , 10.1016/S0140-6736(94)91895-3
Emelia J Benjamin, Daniel Levy, Sonya M Vaziri, Ralph B D'Agostino, Albert J Belanger, Philip A Wolf, Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. ,vol. 271, pp. 840- 844 ,(1994) , 10.1001/JAMA.1994.03510350050036
N.Sheldon Skinner, Jere H. Mitchell, Andrew G. Wallace, Stanley J. Sarnoff, Hemodynamic consequences of atrial fibrillation at constant ventricular rates The American Journal of Medicine. ,vol. 36, pp. 342- 350 ,(1964) , 10.1016/0002-9343(64)90160-3
H R Middlekauff, W G Stevenson, L W Stevenson, Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation. ,vol. 84, pp. 40- 48 ,(1991) , 10.1161/01.CIR.84.1.40
Anne M. Keogh, David W. Baron, John B. Hickie, Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation The American Journal of Cardiology. ,vol. 65, pp. 903- 908 ,(1990) , 10.1016/0002-9149(90)91434-8
William G. Stevenson, Lynne W. Stevenson, Holly R. Middlekauff, Gregg C. Fonarow, Michelle A. Hamilton, Mary A. Woo, Leslie A. Saxon, Paul D. Natterson, Anthony Steimle, Julie A. Walden, Jan H. Tillisch, Improving survival for patients with atrial fibrillation and advanced heart failure Journal of the American College of Cardiology. ,vol. 28, pp. 1458- 1463 ,(1996) , 10.1016/S0735-1097(96)00358-0